Exact Mass: 546.4006

Exact Mass Matches: 546.4006

Found 101 metabolites which its exact mass value is equals to given mass value 546.4006, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Hexaprenyl-6-methoxy-1,4-benzoquinone

2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-6-methoxycyclohexa-2,5-diene-1,4-dione

C37H54O3 (546.4073)


2-Hexaprenyl-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-6-methoxyphenol by ubiquinone biosynthesis monooxygenase Coq6 [EC:1.14.13.-]. 2-Hexaprenyl-6-methoxy-1,4-benzoquinone is then converted into 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis methyltransferase [EC:2.1.1.-]. [HMDB] 2-Hexaprenyl-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-6-methoxyphenol by ubiquinone biosynthesis monooxygenase Coq6 [EC:1.14.13.-]. 2-Hexaprenyl-6-methoxy-1,4-benzoquinone is then converted into 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis methyltransferase [EC:2.1.1.-].

   

3-Hexaprenyl-4-hydroxybenzoic acid

3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-4-hydroxybenzoic acid

C37H54O3 (546.4073)


3-hexaprenyl-4-hydroxybenzoic acid is a member of the class of compounds known as polyprenylphenols. Polyprenylphenols are compounds containing a polyisoprene chain attached to a phenol group. Thus, 3-hexaprenyl-4-hydroxybenzoic acid is considered to be a quinone lipid molecule. 3-hexaprenyl-4-hydroxybenzoic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-hexaprenyl-4-hydroxybenzoic acid can be found in a number of food items such as grass pea, pine nut, muskmelon, and white mustard, which makes 3-hexaprenyl-4-hydroxybenzoic acid a potential biomarker for the consumption of these food products. 3-hexaprenyl-4-hydroxybenzoic acid exists in all eukaryotes, ranging from yeast to humans. In humans, 3-hexaprenyl-4-hydroxybenzoic acid is involved in the ubiquinone biosynthesis. 3-hexaprenyl-4-hydroxybenzoate is an intermediate in ubiquinone biosynthesis and is produced from 4-hydroxybenzoate by the enzyme 4-hydroxybenzoate hexaprenyltransferase.

   

Campesteryl p-coumarate

14-(5,6-Dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (2Z)-3-(4-hydroxyphenyl)prop-2-enoic acid

C37H54O3 (546.4073)


Campesteryl p-coumarate is found in cereals and cereal products. Campesteryl p-coumarate is isolated from corn bra Isolated from corn bran. Campesteryl p-coumarate is found in cereals and cereal products.

   

endo-1,4-beta-Xylanase

benzyl({3-[(4-{[3-(benzyldiethylazaniumyl)propyl]amino}-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]propyl})diethylazanium

C34H50N4O2 (546.3934)


endo-1,4-beta-Xylanase is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans. It is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans

   

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylate

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)


   

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)


   

Trioctyl trimellitate

1,2,4-Trioctyl benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)


   

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Oogoniol 1

Oogoniol 1

C33H54O6 (546.392)


   

25-O-methyl-FD-892

25-O-methyl-FD-892

C33H54O6 (546.392)


   

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.392)


   

hippuristerol B

hippuristerol B

C33H54O6 (546.392)


   

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

C33H54O6 (546.392)


   

crataenoside

crataenoside

C33H54O6 (546.392)


   

polystanin C

polystanin C

C33H54O6 (546.392)


   

(2R)-2-pentaprenylmethyl-7-methoxy-2-methylchromen-6-ol

(2R)-2-pentaprenylmethyl-7-methoxy-2-methylchromen-6-ol

C37H54O3 (546.4073)


   

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.392)


   

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

C33H54O6 (546.392)


   

Campesteryl p-coumarate

14-(5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (2Z)-3-(4-hydroxyphenyl)prop-2-enoate

C37H54O3 (546.4073)


   

ST 27:2;O;Hex

cholest-5,24-dien-3beta-yl beta-D-glucopyranoside

C33H54O6 (546.392)


   

UNII:378539Q830

Tris(2-ethylhexyl) trimellitate

C33H54O6 (546.392)


   

benzyl (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate

benzyl (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate

C37H54O3 (546.4073)


   

Benzyl oleanolate

Benzyl oleanolate

C37H54O3 (546.4073)


   

trioctyl benzene-1,2,4-tricarboxylate

trioctyl benzene-1,2,4-tricarboxylate

C33H54O6 (546.392)


   

Xylanase

Benzoquinonium

C34H50N4O2+2 (546.3934)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist

   

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C33H54O6 (546.392)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C33H54O6 (546.392)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C33H54O6 (546.392)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C33H54O6 (546.392)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C33H54O6 (546.392)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

C33H54O6 (546.392)


   

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C33H54O6 (546.392)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

C33H54O6 (546.392)


   

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C33H54O6 (546.392)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

C33H54O6 (546.392)


   

NAOrn 16:4/11:0

NAOrn 16:4/11:0

C32H54N2O5 (546.4033)


   

2-[Carboxy-(3-octanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-octanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C29H56NO8+ (546.4006)


   

2-[Carboxy-(2-decanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-decanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C29H56NO8+ (546.4006)


   

2-Hexaprenyl-6-methoxy-1,4-benzoquinone

2-Hexaprenyl-6-methoxy-1,4-benzoquinone

C37H54O3 (546.4073)


   

3-Hexaprenyl-4-hydroxybenzoate

3-Hexaprenyl-4-hydroxybenzoic acid

C37H54O3 (546.4073)


   

TG(30:4)

TG(8:0_10:0_12:4)

C33H54O6 (546.392)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

AcHexZyE(0:0)

AcHexZyE(0:0)

C33H54O6 (546.392)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

Hexaprenylmethoxybenzoquinone

Hexaprenylmethoxybenzoquinone

C37H54O3 (546.4073)


   

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.392)


   

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.392)


   

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)


   

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)


   

3-{[(1r,3as,3br,5ar,7r,9ar,9br,11as)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

3-{[(1r,3as,3br,5ar,7r,9ar,9br,11as)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C33H54O6 (546.392)


   

methyl 3-[(3r,3as,4r,5ar,6s,7s,9ar,9br)-4-(acetyloxy)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[(3r,3as,4r,5ar,6s,7s,9ar,9br)-4-(acetyloxy)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)


   

(1s,2s,4ar,4bs,6as,11as,11br,13ar)-2,10-dihydroxy-1,4a,6a,11b-tetramethyl-1-{2-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]ethyl}-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7-carbaldehyde

(1s,2s,4ar,4bs,6as,11as,11br,13ar)-2,10-dihydroxy-1,4a,6a,11b-tetramethyl-1-{2-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]ethyl}-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7-carbaldehyde

C37H54O3 (546.4073)


   

5-(acetyloxy)-5-{7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate

5-(acetyloxy)-5-{7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate

C33H54O6 (546.392)


   

methyl 3-{3-[7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl}propanoate

methyl 3-{3-[7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl}propanoate

C33H54O6 (546.392)


   

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate

C33H54O6 (546.392)


   

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.392)


   

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methoxy-6-methylheptanoic acid

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methoxy-6-methylheptanoic acid

C33H54O6 (546.392)


   

16-(7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl)-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

16-(7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl)-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

C33H54O6 (546.392)


   

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C33H54O6 (546.392)


   

methyl 22-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}docosanoate

methyl 22-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}docosanoate

C33H54O6 (546.392)


   

(3e,5e,7r,8r,9e,13e,16s)-16-[(2s,4e,7s,8r,9r,10s,11s)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

(3e,5e,7r,8r,9e,13e,16s)-16-[(2s,4e,7s,8r,9r,10s,11s)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

C33H54O6 (546.392)


   

3-({1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

3-({1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.392)


   

(1r,2s,3s)-1-[(1s,3's,3as,3br,5as,7r,9as,9bs,11as)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate

(1r,2s,3s)-1-[(1s,3's,3as,3br,5as,7r,9as,9bs,11as)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate

C33H54O6 (546.392)


   

(1r,2s,5s,13s,14r,17r,18s,21s,26s,28s)-10-hydroxy-1,5,14,18,22,22,26-heptamethyl-27-oxaheptacyclo[15.13.0.0²,¹⁴.0⁵,¹³.0⁶,¹¹.0¹⁸,²⁸.0²¹,²⁶]triaconta-6,8,10-triene-7-carbaldehyde

(1r,2s,5s,13s,14r,17r,18s,21s,26s,28s)-10-hydroxy-1,5,14,18,22,22,26-heptamethyl-27-oxaheptacyclo[15.13.0.0²,¹⁴.0⁵,¹³.0⁶,¹¹.0¹⁸,²⁸.0²¹,²⁶]triaconta-6,8,10-triene-7-carbaldehyde

C37H54O3 (546.4073)